EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Prognostic Role of Prolactin-Induced Protein (PIP) in Breast Cancer

Natalia Sauer iD, Igor Matkowski iD, Grażyna Bodalska, Marek Murawski, Piotr Dzięgiel, Jacek Calik

Cells · 11.09.2023 · 12 (18) · 2252

DOI: 10.3390/cells12182252 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 11.09.2023. Verfasst von Natalia Sauer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, Poland. Hauptthemen laut MEDLINE: Breast Neoplasms, Carrier Proteins. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prolactin-inducible protein (PIP), also referred to as gross cystic disease fluid protein 15 (GCDFP-15), has been a trending topic in recent years due to its potential role as a specific marker in breast cancer. PIP binds to aquaporin-5 (AQP5), CD4, actin, fibrinogen, β-tubulin, serum albumin, hydroxyapatite, zinc α2-glycoprotein, and the Fc fragment of IgGs, and the expression of PIP has been demonstrated to be modulated by various cytokines, including IL4/13, IL1, and IL6. PIP gene expression has been extensively studied due to its captivating nature. It is influenced by various factors, with androgens, progesterone, glucocorticosteroids, prolactin, and growth hormone enhancing its expression while estrogens suppress it. The regulatory mechanisms involve important proteins such as STAT5A, STAT5B, Runx2, and androgen receptor, which collaborate to enhance PIP gene transcription and protein production. The expression level of PIP in breast cancer is dependent on the tumor stage and subtype. Higher expression is observed in early-stage tumors of the luminal A subtype, while lower expression is associated with luminal B, basal-like, and triple-negative subtypes, which have a poorer prognosis. PIP expression is also correlated with apocrine differentiation, hormone receptor positivity, and longer metastasis-free survival. PIP plays a role in supporting the immune system’s antitumor response during the early stages of breast cancer development. However, as cancer progresses, the protective role of PIP may become less effective or diminished. In this work, we summarized the clinical significance of the PIP molecule in breast cancer and its potential role as a new candidate for cell-based therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCarrier ProteinsHumansFemalePrognosisGene Expression Regulation, NeoplasticBiomarkers, TumorMembrane Transport Proteins

Stichwörter der Autor:innen

breast cancergross cystic disease fluid protein 15 (GCDFP-15)prolactin-inducible protein (PIP)

Substanzen

PIP protein, humanBiomarkers, TumorCarrier ProteinsMembrane Transport Proteins

Autor:innen und Institutionen

  • Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, Poland.
  • Old Town Clinic, 50-127 Wroclaw, Poland.
  • Jan Mikulicz-Radecki University Teaching Hospital, Borowska 213, 50-556 Wroclaw, Poland.
  • Faculty of Medicine, Wroclaw Medical University, 50-556 Wroclaw, Poland.
  • 1st Department and Clinic of Gynecology and Obstetrics, Wroclaw Medical University, 50-556 Wroclaw, Poland.
  • Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, T. Chalubinskiego 6a, 50-368 Wroclaw, Poland.

ORCID-Profile: Natalia Sauer, Igor Matkowski

Zitieren

APA

Sauer, N., Matkowski, I., Bodalska, G., Murawski, M., Dzięgiel, P., & Calik, J. (2023). Prognostic Role of Prolactin-Induced Protein (PIP) in Breast Cancer. Cells, 12(18), 2252. https://doi.org/10.3390/cells12182252

Vancouver

Sauer N, Matkowski I, Bodalska G, Murawski M, Dzięgiel P, Calik J. Prognostic Role of Prolactin-Induced Protein (PIP) in Breast Cancer. Cells. 2023;12(18):2252. doi:10.3390/cells12182252

BibTeX
@article{Sauer2023,
  author = {Sauer, Natalia and Matkowski, Igor and Bodalska, Grażyna and Murawski, Marek and Dzięgiel, Piotr and Calik, Jacek},
  title = {Prognostic Role of Prolactin-Induced Protein (PIP) in Breast Cancer},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {18},
  pages = {2252},
  doi = {10.3390/cells12182252}
}
Kostenlos starten →